BCN Biosciences, LLC

Pasadena, CA 91107

SBIR Award Summary

Total Number of Awards 4
Total Value of Awards $575K
First Award Date 09/01/08
Most Recent Award Date 05/19/14

Key Personnel

Last Name Name Awards Contact
Varnum Brian Varnum 1
Norris Andrew John Norris 3
Gresser Michael J Gresser 1

4 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-13-088
Budget: 05/19/14 - 03/18/15

ABSTRACT: This proposal entitled "A dual acting drug for enhancing radiotherapeutic benefit" is designed to provide proof of concept evidence that the novel compound EWA001 can protect normal lung tissue from radiation-induced damage within an in vivo model without appreciably protecting neoplastic tissue. The protection of radiation induced lu...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-09-080
Budget: 09/03/10 - 02/28/12

DESCRIPTION (provided by applicant): Cancer is the leading cause of mortality in the United States, despite many advances in the current therapies including surgery, radiation and chemotherapy. Therefore, it is imperative that novel targets for cancer therapeutic development are identified and explored in order to improve the outcome of this let...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-20
Budget: 09/22/08 - 09/21/09

DESCRIPTION (provided by applicant): In a screen for naturally occurring angiogenic inhibitors, we have identified an extract from the plant Livistona chinensis, which has potent anti-angiogenic and anti-tumor activity and is non-toxic in mice. To our knowledge, ours is the first publication in the English literature on this extract from Livisto...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-07-80
Budget: 09/01/08 - 08/31/09

DESCRIPTION (provided by applicant): Natural products possess the richest source of molecular diversity in existence. In the case of cancer therapeutics, natural products have yielded a significant number of novel and effective cancer treatment and preventive agents. As a commercial venture, BCN Biosciences has a commitment to identifying new ch...